Clinical Trials

Phase I Clinical Trial: A Phase I, Multi-Center, Open-Label, Dose Escalation Study of Trombosomes® in Bleeding Thrombocytopenic Patients in Three Cohorts
Status: Currently Recruiting
Learn More

Exploratory Phase I trial: Safety evaluation of lyophilized platelet-derived hemostatic product
Status: Completed 2016
Learn More


Have Questions?Reach us here

Please enter your information below

The Cellphire Method

Cellphire has developed a proprietary method for the stabilization of blood cells in the dry state. The first application of this technology is to develop long term stabilization of platelets as a hemostatic agent.